SCHEMBL18875111

SCHEMBL18875111

c1ccc2c(c1)Oc1ccccc1N2c1cc(-c2nc3ccccc3o2)cc(N2c3ccccc3Oc3ccccc32)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 10/20 0.50
KDM4E B2RXH2 9/20 0.50
HPGD P15428 8/20 0.50
ALDH1A1 P00352 7/20 0.50
HSD17B10 Q99714 5/20 0.50
TP53 P04637 5/20 0.50
KMT2A Q03164 4/20 0.50
MEN1 O00255 3/20 0.50
PKM P14618 1/20 0.50
NPC1 O15118 10/20 0.47
RAB9A P51151 8/20 0.47
ATM Q13315 1/20 0.46
CASP3 P42574 3/20 0.42
SENP7 Q9BQF6 3/20 0.42
SENP6 Q9GZR1 3/20 0.42
HCRTR1 O43613 2/20 0.42
MAPT P10636 2/20 0.42
SENP8 Q96LD8 2/20 0.42
USP2 O75604 1/20 0.42
TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18875157 0.97 SMN1; SMN2 (0.48) SMN1; SMN2KDM4EHPGDALDH1A1HSD17B10
SCHEMBL18875100 0.97 SMN1; SMN2 (0.50) SMN1; SMN2KDM4EHPGDALDH1A1HSD17B10
SCHEMBL18875136 0.96 SMN1; SMN2 (0.49) SMN1; SMN2KDM4EHPGDALDH1A1HSD17B10
SCHEMBL18875236 0.91 KDM4E (0.46) SMN1; SMN2KDM4EHPGDALDH1A1HSD17B10
SCHEMBL18875226 0.90 KDM4E (0.64) SMN1; SMN2KDM4EHPGDALDH1A1HSD17B10
SCHEMBL18875255 0.88 SMN1; SMN2 (0.43) SMN1; SMN2KDM4EHPGDALDH1A1HSD17B10
SCHEMBL17038507 0.88 NPC1 (0.61) SMN1; SMN2KDM4EHPGDALDH1A1HSD17B10
SCHEMBL18875229 0.87 KDM4E (0.42) SMN1; SMN2KDM4EHPGDALDH1A1HSD17B10
SCHEMBL18875130 0.86 ALDH1A1 (0.42) SMN1; SMN2KDM4EHPGDALDH1A1HSD17B10
SCHEMBL18875127 0.86 HSD17B10 (0.42) SMN1; SMN2KDM4EHPGDALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170148996-A1 ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC OPTOELECTRONIC DEVICES COMPRISING THE SAME WUHAN TIANMA MICROELECTRONICS CO., LTD.SHANGHAI BRANCH (CN) 2017-05-25 US disclosed
US-20170148996-A1 ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC OPTOELECTRONIC DEVICES COMPRISING THE SAME WUHAN TIANMA MICROELECTRONICS CO., LTD.SHANGHAI BRANCH (CN) 2017-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170148996-A1 ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC OPTOELECTRONIC DEVICES COMPRISING THE SAME OR10J3, PPOX, OR51E2 SMN1; SMN2 4625/4885KDM4E 2416/4885HPGD 2640/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.